Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

被引:7
|
作者
Yan, Yixin [1 ]
Tian, Minjie [1 ]
Wang, Tong [1 ]
Wang, Xixi [1 ]
Wang, Yingying [1 ]
Shi, Jingping [1 ]
机构
[1] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
transcranial magnetic stimulation; Alzheimer's disease; mild cognitive impairment; cognition; meta-analysis; cerebellum; NONINVASIVE BRAIN-STIMULATION; DOUBLE-BLIND; RTMS; INTERVENTION; EXCITABILITY; DEMENTIA; SPEECH; APATHY; TMS;
D O I
10.3389/fneur.2023.1209205
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionTranscranial magnetic stimulation (TMS) is a non-invasive intervention that holds promise for improving cognitive function in individuals with Alzheimer's disease (AD). However, the effectiveness of this therapy and the optimal TMS parameters has not reached a consensus. The purpose of the meta-analysis was to systematically discern the effectiveness of different components of TMS protocols on cognitive improvement in patients with mild cognitive impairment (MCI) and AD.MethodsThe meta-analysis was preregistered on Prospero (registration number: CRD42022345482). PubMed, Web of Science, Science Direct, and Cochrane Library databases were used to search, screen and identify eligible studies with the following keywords: Transcranial Magnetic Stimulation OR TMS OR theta burst stimulation AND Alzheimer OR Alzheimers OR Alzheimer's OR mild cognitive impairment OR MCI. Randomized controlled trials (RCTs) of participants with accepted standardized diagnostic criteria were searched by two authors independently. The risk of bias was assessed using an adapted Cochrane Risk of Bias tool. Standardized mean difference (SMD) and 95% confidence interval (CI) were calculated using the random-effects models. Subgroup analyses were performed to investigate the influential factors.ResultsA total of 21 studies and 25 trials were included in this meta-analysis. The findings revealed a significant overall cognition improvement of real stimulation compared with sham stimulation (short-term effects: SMD, 0.91; 95% CI 0.44-1.38; P < 0.01; long-lasting effects: SMD, 0.91; 95% CI 0.27-1.55; P < 0.01). Subgroup analysis demonstrated that stimulation of the left dorsolateral prefrontal cortex and bilateral cerebellums, as well as moderate frequency stimulation (5 Hz and 10 Hz) on mild and moderate cognitive impairment patients, were more effective than other TMS protocols. However, the additional application of cognitive training showed no significant improvement.ConclusionCognitive improvement effect of TMS was demonstrated in MCI and AD patients in both short-term assessment and long-lasting outcomes, and the efficiency of TMS is affected by the stimulation frequency, stimulation site, and participant characteristics. Further RCTs are needed to validate the findings of our subgroup analysis.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis
    Zhou, Futao
    Sun, Yangyan
    Xie, Xinhua
    Zhao, Yushi
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [32] Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review
    Hosseini, Mahboobeh
    Poljak, Anne
    Braidy, Nady
    Crawford, John
    Sachdev, Perminder
    AGEING RESEARCH REVIEWS, 2020, 60
  • [33] Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis
    Jemimah, Sherlyn
    Chabib, Chahd Maher Musthafa
    Hadjileontiadis, Leontios
    AlShehhi, Aamna
    PLOS ONE, 2023, 18 (05):
  • [34] Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis
    Su, Cen
    Zhao, Kangren
    Xia, Haiping
    Xu, Yaoming
    PSYCHOGERIATRICS, 2019, 19 (04) : 300 - 309
  • [35] Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Opwonya, Julius
    Doan, Dieu Ni Thi
    Kim, Seul Gee
    Kim, Joong Il
    Ku, Boncho
    Kim, Soochan
    Park, Sunju
    Kim, Jaeuk U.
    NEUROPSYCHOLOGY REVIEW, 2022, 32 (02) : 193 - 227
  • [36] Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
    Futao Zhou
    Yangyan Sun
    Xinhua Xie
    Yushi Zhao
    Alzheimer's Research & Therapy, 15
  • [37] Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
    Zhang, Heng
    Wang, Yan
    Lyu, Diyang
    Li, Yan
    Li, Wenwen
    Wang, Qi
    Qin, Qi
    Wang, Xuechu
    Gong, Min
    Jiao, Haishan
    Liu, Wenying
    Jia, Jianping
    AGEING RESEARCH REVIEWS, 2021, 71
  • [38] Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Singh, Balwinder
    Parsaik, Ajay K.
    Mielke, Michelle M.
    Erwin, Patricia J.
    Knopman, David S.
    Petersen, Ronald C.
    Roberts, Rosebud O.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (02) : 271 - 282
  • [39] Exploring the potential of combining transcranial magnetic stimulation and electroencephalography to investigate mild cognitive impairment and Alzheimer's disease: a systematic review
    Hall, J. D.
    Green, Jacob M.
    Chen, Yu-Chin A.
    Liu, Yilin
    Zhang, Hangbin
    Sundman, Mark H.
    Chou, Ying-hui
    GEROSCIENCE, 2024, 46 (04) : 3659 - 3693
  • [40] Sleep, Cognitive impairment, and Alzheimer's disease: A Systematic Review and Meta-Analysis
    Bubu, Omonigho M.
    Brannick, Michael
    Mortimer, James
    Umasabor-Bubu, Ogie
    Sebastiao, Yuri V.
    Wen, Yi
    Schwartz, Skai
    Borenstein, Amy R.
    Wu, Yougui
    Morgan, David
    Anderson, William M.
    SLEEP, 2017, 40 (01)